Proliferation markers in tumours: interpretation and clinical value

被引:159
作者
van Diest, PJ
Brugal, G
Baak, JPA
机构
[1] Free Univ Amsterdam Hosp, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
[2] Univ Grenoble 1, Inst Albert Bonniot, Grenoble, France
关键词
D O I
10.1136/jcp.51.10.716
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
[No abstract available]
引用
收藏
页码:716 / 724
页数:9
相关论文
共 184 条
[1]   PROLIFERATING-CELL NUCLEAR ANTIGEN (PC10) IMMUNOLABELING AND OTHER PROLIFERATION INDEXES AS PROGNOSTIC FACTORS IN BREAST-CANCER [J].
AALTOMAA, S ;
LIPPONEN, P ;
PAPINAHO, S ;
SYRJANEN, K .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1993, 119 (05) :288-294
[2]  
AALTOMAA S, 1992, ONCOLOGY, V49, P93
[3]   NUCLEOLAR ORGANIZER REGIONS RELATED TO MORPHOMETRY, FLOW-CYTOMETRY, SEX STEROID-RECEPTOR CONTENT, TUMOR HISTOLOGY AND PROGNOSIS IN FEMALE BREAST-CANCER [J].
AALTOMAA, S ;
LIPPONEN, P ;
SYRJANEN, K .
PATHOLOGY RESEARCH AND PRACTICE, 1993, 189 (04) :416-421
[4]   PROGNOSTIC FACTORS IN AXILLARY LYMPH NODE-NEGATIVE (PN-) BREAST CARCINOMAS [J].
AALTOMAA, S ;
LIPPONEN, P ;
ESKELINEN, M ;
KOSMA, VM ;
MARIN, S ;
ALHAVA, E ;
SYRJANEN, K .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) :1555-1559
[5]   MITOTIC-ACTIVITY IN NON-HODGKINS-LYMPHOMA - RELATION TO THE KIEL CLASSIFICATION AND TO PROGNOSIS [J].
AKERMAN, M ;
BRANDT, L ;
JOHNSON, A ;
OLSSON, H .
BRITISH JOURNAL OF CANCER, 1987, 55 (02) :219-223
[6]   LEIOMYOSARCOMA VERSUS BIZARRE AND CELLULAR LEIOMYOMAS OF THE UTERUS - A COMPARATIVE-STUDY BASED ON THE MIB-1 AND PROLIFERATING CELL NUCLEAR ANTIGEN INDEXES, P53 EXPRESSION, DNA FLOW-CYTOMETRY, AND MUSCLE-SPECIFIC ACTINS [J].
AMADA, S ;
NAKANO, H ;
TSUNEYOSHI, M .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1995, 14 (02) :134-142
[7]  
Baak J. P. A., 1995, Journal of Pathology, V176, p49A
[8]  
Baak JP, 1991, Manual of quantitative pathology in cancer diagnosis and prognosis
[9]   PROGNOSTIC INDICATORS IN BREAST-CANCER - MORPHOMETRIC METHODS [J].
BAAK, JPA ;
KURVER, PHJ ;
DESNOONIEWLAAT, AJE ;
DEGRAEF, S ;
MAKKINK, B ;
BOON, ME .
HISTOPATHOLOGY, 1982, 6 (03) :327-339
[10]   THE PROGNOSTIC VALUE OF MORPHOMETRICAL FEATURES AND CELLULAR DNA CONTENT IN CISPLATIN TREATED LATE OVARIAN-CANCER PATIENTS [J].
BAAK, JPA ;
SCHIPPER, NW ;
WISSEBREKELMANS, ECM ;
CEELEN, T ;
BOSMAN, FT ;
VANGEUNS, H ;
WILS, J .
BRITISH JOURNAL OF CANCER, 1988, 57 (05) :503-508